These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17573001)

  • 21. The role of recombinant human elafin in the resistance of A549 cells against Pseudomonas aeruginosa biofilm.
    Li Q; Zhou X; Nie X; Yang J
    Respiration; 2010; 79(1):68-75. PubMed ID: 19420899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa twitching motility: type IV pili in action.
    Burrows LL
    Annu Rev Microbiol; 2012; 66():493-520. PubMed ID: 22746331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa twitching motility-mediated chemotaxis towards phospholipids and fatty acids: specificity and metabolic requirements.
    Miller RM; Tomaras AP; Barker AP; Voelker DR; Chan ED; Vasil AI; Vasil ML
    J Bacteriol; 2008 Jun; 190(11):4038-49. PubMed ID: 18390654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of virulence factors of Pseudomonas aeruginosa by erythromycin.
    Kita E; Sawaki M; Oku D; Hamuro A; Mikasa K; Konishi M; Emoto M; Takeuchi S; Narita N; Kashiba S
    J Antimicrob Chemother; 1991 Mar; 27(3):273-84. PubMed ID: 1903786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa exhibits directed twitching motility up phosphatidylethanolamine gradients.
    Kearns DB; Robinson J; Shimkets LJ
    J Bacteriol; 2001 Jan; 183(2):763-7. PubMed ID: 11133973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extragenic suppressor mutations that restore twitching motility to fimL mutants of Pseudomonas aeruginosa are associated with elevated intracellular cyclic AMP levels.
    Nolan LM; Beatson SA; Croft L; Jones PM; George AM; Mattick JS; Turnbull L; Whitchurch CB
    Microbiologyopen; 2012 Dec; 1(4):490-501. PubMed ID: 23233287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythromycin inhibits Pseudomonas aeruginosa-induced tumour necrosis factor-alpha production in human whole blood.
    Schultz MJ; Speelman P; van der Poll T
    J Antimicrob Chemother; 2001 Aug; 48(2):275-8. PubMed ID: 11481300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of erythromycin on production of cytotoxin and attachment factors of bacteria].
    Mikasa K; Kita E; Sawaki M; Konishi M; Maeda K; Hamada K; Takeuchi S; Sakamoto M; Kunimatsu M; Kashiba S
    Kansenshogaku Zasshi; 1993 Jul; 67(7):648-53. PubMed ID: 8103071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of pretreatment by erythromycin or rokitamycin on aminoglycoside inactivating enzyme of Pseudomonas aeruginosa].
    Ohara K; Nakagawa M; Kawabe T; Sawai T
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():92-4. PubMed ID: 9597454
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro.
    Tsang KW; Ng P; Ho PL; Chan S; Tipoe G; Leung R; Sun J; Ho JC; Ip MS; Lam WK
    Eur Respir J; 2003 Mar; 21(3):401-6. PubMed ID: 12661992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin.
    Molinari G; Paglia P; Schito GC
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):469-71. PubMed ID: 1330564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of erythromycin on Pseudomonas aeruginosa and neutrophil mediated epithelial damage.
    Tanaka E; Kanthakumar K; Cundell DR; Tsang KW; Taylor GW; Kuze F; Cole PJ; Wilson R
    J Antimicrob Chemother; 1994 Apr; 33(4):765-75. PubMed ID: 8056695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vertical confinement enhances surface exploration in bacterial twitching motility.
    Chen X; Zhang R; Yuan J
    Environ Microbiol; 2024 Jul; 26(7):e16679. PubMed ID: 39039815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twitching motility and cAMP levels: signal transduction through a single methyl-accepting chemotaxis protein.
    Jansari VH; Potharla VY; Riddell GT; Bardy SL
    FEMS Microbiol Lett; 2016 Jun; 363(12):. PubMed ID: 27190147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing bacterial resistance to antibiotics with ultrasound.
    Rediske AM; Rapoport N; Pitt WG
    Lett Appl Microbiol; 1999 Jan; 28(1):81-4. PubMed ID: 10030038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of complex behavior in pili-based motility in early stages of P. aeruginosa surface adaptation.
    Brill-Karniely Y; Jin F; Wong GC; Frenkel D; Dobnikar J
    Sci Rep; 2017 Apr; 7():45467. PubMed ID: 28393835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collective Dynamics of Model Pili-Based Twitcher-Mode Bacilliforms.
    Nagel AM; Greenberg M; Shendruk TN; de Haan HW
    Sci Rep; 2020 Jul; 10(1):10747. PubMed ID: 32612117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of erythromycin on Pseudomonas aeruginosa pyocyanine-induced IL-8 production and its biological activity (the 2nd report)].
    Nishimura J; Sato K; Sugamori T; Muranaka H; Tomoshima Y; Takahashi T; Okamoto T; Ichian H
    Jpn J Antibiot; 1998 Jan; 51 Suppl A():116-9. PubMed ID: 9597503
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pyocyanine synthesis by Pseudomonas aeruginosa in chronic airway infection and the effect of erythromycin on its biological activity].
    Sato K; Suga M; Nishimura J; Kushima Y; Muranaka H; Ando M
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():89-91. PubMed ID: 9597453
    [No Abstract]   [Full Text] [Related]  

  • 40. A phage protein-derived antipathogenic peptide that targets type IV pilus assembly.
    Chung IY; Kim BO; Han JH; Park J; Kang HK; Park Y; Cho YH
    Virulence; 2021 Dec; 12(1):1377-1387. PubMed ID: 34008466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.